GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Charmacy Pharmaceutical Co 2289.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

5.49

—

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

About Charmacy Pharmaceutical Co

Its shares trade on HKEX under the ticker 2289.HK. It has been listed since 14 December 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥4.38bn and net income of CN¥46.3m. At that date it held total assets of CN¥3.96bn and shareholders' equity of CN¥616.6m.

Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business. The company is headquartered in Shantou, Guangdong. The company went IPO on 2015-12-14. The products also include healthcare medicine, traditional Chinese drinking tablets, traditional Chinese medicine and medical equipment. Through its subsidiaries, the Company is also engaged in the trading of pharmaceutical products and provision of related services.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
14 Dec 2015
Employees
811
Website
chmyy.com ↗

Leadership

Pay as last reported

  • Mr. Jingbin YanNon-Executive Chairman of the Board
  • Mr. Chuanglong YaoChief Executive Officer, Executive Vice Chairman of the Board, since 2000CN¥210,000
  • Ms. Hanzi ZhangFinance Director - Person-in-Charge of Finance, Executive Director, since 2022
  • Mr. Jianbo FanChief Technology Officer, Vice President, Executive Director, since 2015
  • Ms. Yuyan ZhengChief Marketing Officer, Vice President, Executive Director, since 2015
  • Mr. Zhijie LinVice Logistics Officer
  • Ms. Wai ling WongJoint Company Secretary
  • Ms. Jiexi YaoJoint Company Secretary
  • Ms. Zhen FuNon-Executive Director
  • Mr. Fei XuNon-Executive Director
  • Mr. Jian GuanNon-Executive Independent Director
  • Mr. Hanguo LiNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Charmacy Pharmaceutical Co Ltd employs 811 full-time employees in Shantou, Guangdong.
  • The company distributes healthcare medicine and traditional Chinese drinking tablets nationwide.
  • Charmacy's subsidiaries trade pharmaceutical products and provide related services effectively.

Weaknesses

  • Charmacy Pharmaceutical Co Ltd has no subsidiaries in major international markets.
  • The company's business is limited to pharmaceutical distribution in China.
  • Charmacy's IPO date was 14 December 2015, showing limited market history.

Opportunities

  • Charmacy can expand its traditional Chinese medicine business in the Chinese market.
  • Growing demand for healthcare medicine in China presents new opportunities.
  • The company can leverage its subsidiaries for broader pharmaceutical trading.

Threats

  • Charmacy faces competition from other Chinese pharmaceutical distributors.
  • Regulatory changes in China's Health Care sector could impact operations.
  • The company's reliance on traditional Chinese medicine may limit growth.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.